A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...
A U.S. regulator reportedly plans to unveil a faster approach to approving custom gene-editing treatments for rare diseases.
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
DELRAY BEACH, Fla., Oct. 31, 2025 /PRNewswire/ — According to MarketsandMarkets™, The agriculture biotechnology market is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback